Open Heart

JUNE 6, 2023

Objective Pulmonary hypertension (PHT) commonly coexists with significant mitral regurgitation (MR), but its prevalence and prognostic importance have not been well characterised. In a large cohort of adults with moderate or greater MR, we aimed to describe the prevalence and severity of PHT and assess its influence on outcomes.

Bicuspid/Mitral 52

Bicuspid/Mitral Pulmonary Hypertension Outcomes 52

Circulation: Cardiovascular Interventions

NOVEMBER 6, 2023

Background:Neonates with complex congenital heart disease and pulmonary overcirculation have been historically treated surgically. Pulmonary arteries grew adequately for age, and devices were easily removed without complications. However, subcohorts may benefit from less invasive procedures. kilograms [IQR, 2.1–3.3])

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

Frontiers in Cardiovascular Medicine

JANUARY 11, 2024

Objective Early risk assessment of pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) is crucial to ensure timely treatment. A residual neural networks (ResNet) was trained for classify VSD patients with different outcomes based on chest radiographs.

VSD 59

VSD Pulmonary Congenital Heart Disease Congenital 59

Heart BMJ

DECEMBER 20, 2023

Objective Despite recent advances in surgical and interventional techniques, knowledge on the management of carcinoid heart disease (CHD) remains limited. In a cohort of patients with liver metastases of midgut neuroendocrine tumours (NETs), we aimed to describe the perioperative management and short-term outcomes of CHD.

Heart Disease 40

Heart Disease Tricuspid Outcomes Heart Failure 40

Frontiers in Cardiovascular Medicine

JULY 5, 2024

IntroductionPrimary pulmonary vein stenosis (PVS) is a rare congenital heart disease that proves to be a clinical challenge due to the rapidly progressive disease course and high rates of treatment complications. These 3D reconstructions were 3D printed using a clear resin ink and used in a benchtop experimental setup.

Stenosis 52

Stenosis Pulmonary Congenital Heart Disease Stents 52

Open Heart

DECEMBER 15, 2022

The aim of this study was to investigate the association of preoperative imaging and haemodynamic data derived from echocardiography (ECHO), cardiac magnetic resonance (CMR) and right heart catheterisation (RHC) with postoperative outcomes following TVS. The primary outcome occurred in 16 patients (27%) with a 1-year mortality of 7%.

Tricuspid 52

Tricuspid Outcomes Congenital Heart Disease Congenital 52

Frontiers in Cardiovascular Medicine

MAY 8, 2024

Pulmonary arterial hypertension (PAH) is a chronic and progressive disease that eventually leads to heart failure (HF) and subsequent fatality if left untreated. Right ventricular (RV) function has proven prognostic values in patients with a variety of heart diseases including PAH.

Pulmonary 40

Pulmonary Hypertension Heart Disease Article 40

Frontiers in Cardiovascular Medicine

MARCH 3, 2025

Data collection included demographic characteristics, clinical outcomes, hospitalization details, and surgical treatment. Pulmonary vein abnormalities were observed in 4 ouf of 7 (57.1%) patients and atrial septal defects in 2 out of 7 patients (28.5%).

Congenital 52

Congenital Congenital Heart Disease Risk Factors Pulmonary 52

DAIC

DECEMBER 19, 2023

Ischemic heart failure is a common outcome in people who have had previous vascular disease and patients are at increased risk for accelerated decline and serious complications associated with their condition,” said Debby Holmes Higgin, BioCardia’s Vice President of Clinical. BioCardia’s President and CEO. “We

Heart Failure 105

Heart Failure Interventional Cardiology Pulmonary Heart Disease 105

Circulation: Cardiovascular Imaging

JANUARY 13, 2025

Disorders of the pulmonic valve (PV) receive considerably less attention than other forms of valvular heart disease.

Congenital Heart Disease 40

Congenital Heart Disease Anatomy Congenital Heart Disease 40

Ken Grauer, MD

FEBRUARY 28, 2023

These 2 settings are: i ) In patients with severe , often longstanding pulmonary disease ; and / or , ii ) In acutely ill patients with multi-system disease ( ie, sepsis, shock, electrolyte and/or acid-base disorders ). Acute Right Heart Strain. Hypoxic injury ( from pneumonia or other acute pulmonary complication ).

Blog 78

Blog COVID-19 AFIB Pulmonary 78

Dr. Smith's ECG Blog

MARCH 11, 2012

There was no pulmonary edema or hypoxia. Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 Approach to Wide Complex Tachycardia Unstable – Shock it 12-lead if at all possible --Unstable defined by : Chest Pain Shock Hypotension Very dyspneic Pulmonary Edema Stable Get a 12-lead ECG Sinus? He was intubated.

Tachycardia 52

Tachycardia Chest Pain Pulmonary Blood Pressure 52

Open Heart

DECEMBER 14, 2023

Objective To determine the magnitude of any excess risk of mortality and hospitalisation due to COVID-19 infection in patients with congenital heart disease (CHD) in the UK healthcare system. Of patients with a positive COVID-19 test, patients with CHD were more likely than controls to be hospitalised (22.4%

COVID-19 98

COVID-19 Congenital Heart Disease Congenital Heart Disease 98

DAIC

FEBRUARY 24, 2025

Meanwhile, traditional methods for cardiac detection still rely on reactive, symptom-driven interventions that often catch heart disease too late, when treatment is complex, critical and costly. AI-enabled remote cardiac monitoring is is already revolutionizing how we detect, diagnose, mitigate and manage heart conditions.

Hospital 52

Hospital Cardiovascular Disease Heart Failure Heart Attack 52

Open Heart

SEPTEMBER 13, 2024

Background To determine the frequency of pregnancy complications and their association with the risk of cardiovascular outcomes in women with structural heart disease (SHD). The outcomes were cardiovascular mortality and hospitalisations defined from the Cause of Death Register and the National Patient Register.

Heart Disease 52

Heart Disease Congenital Heart Disease Congenital Hypertension 52

DAIC

FEBRUARY 22, 2024

El-Hamamsy will focus on fostering collaboration among cardiologists, surgeons, and researchers, as well as promoting awareness and encouraging innovation to reduce the burden of heart valve disease globally.

Heart Valves 142

Heart Valves Aortic valve Aortic Sudden Cardiac Death 142

Journal of the American Heart Association

JANUARY 17, 2025

However, the cause and risk factors for mortality remain uncertain.MethodsThis retrospective, singlecenter study identified children with primary and secondary pulmonary vein stenosis through a cardiac catheterization database. P=0.032), and the presence of congenital heart disease (HR, 2.4 [95% 95% CI, 2.214.1];P<0.001).

Stenosis 76

Stenosis Pulmonary Sudden Cardiac Death Pediatrics 76

Circulation: Cardiovascular Imaging

DECEMBER 16, 2024

BACKGROUND:Right ventricular-arterial coupling (RVAC) describes the relationship between right ventricular contractility and pulmonary vascular afterload. In a retrospective analysis, hybrid (echo and invasive) RVAC metrics included TAPSE/pulmonary vascular resistance (PVRi) and RVFW-LS/PVRi.

Pediatrics 40

Pediatrics Pulmonary Congenital Heart Disease Hypertension 40

Circulation

NOVEMBER 11, 2024

Background:Patients with adult congenital heart disease (ACHD) form a unique subset of patients with complex ventricular tachycardia (VT).Objective:To Background:Patients with adult congenital heart disease (ACHD) form a unique subset of patients with complex ventricular tachycardia (VT).Objective:To

Congenital Heart Disease 40

Congenital Heart Disease Congenital Tachycardia Heart Disease 40

Open Heart

JULY 17, 2023

Congenital heart disease (CHD) is likely to increase vulnerability and understanding the predictors of adverse outcomes is key to optimising care. Objective Ascertain the impact of COVID-19 on people with CHD and define risk factors for adverse outcomes. to 7.97 (p=0.01)) and genetic disease (OR 2.87, 95% CI 1.04

COVID-19 40

COVID-19 Congenital Heart Disease Congenital Heart Disease 40

DAIC

MAY 16, 2024

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

DAIC

JULY 25, 2024

About Chronic Heart Failure of Reduced Ejection Fraction (HFrEF) Heart failure of reduced ejection fraction (HFrEF) is a clinical condition in which the output of blood from the heart is insufficient to meet the metabolic demands of the body. mtaschetta-millane Thu, 07/25/2024 - 09:08 July 25, 2024 — BioCardia, Inc. ,

Heart Failure 111

Heart Failure Quality of Life CMS Reimbursement 111

Heart BMJ

MARCH 22, 2024

Methods This was a retrospective analysis of the Verona Valvular Heart Disease Registry (Italy) including 250 patients (83 (80–86) years, 53% female) with severe AS who underwent TAVI between 2019 and 2021. The primary endpoint was the composite of cardiovascular death and rehospitalisation for heart failure (HF).

Aortic valve 40

Aortic valve Aortic Tricuspid Heart Failure 40

European Journal of Heart Failure

DECEMBER 22, 2023

1.65), chronic kidney disease (HR 1.37, 95%CI 1.34-1.41), 1.41), chronic obstructive pulmonary disease (HR 1.32, 95%CI 1.28-1.35). Occurrence of CV and non-CV outcomes was related to the number of CV and non-CV comorbidities, respectively. Obesity was associated with a lower risk of all-cause death (HR 0.81, 95%CI 0.79-0.84).

Heart Failure 40

Heart Failure Coronary Artery Disease Kidney Disease Dementia 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Journal of the American Heart Association

MARCH 13, 2025

BackgroundSparce data suggest higher mortality in heart failure (HF) with left ventricular ejection fraction (EF) >65% to 70%. We characterized EF distribution, characteristics, and outcomes in patients with HF and EF 50%.Methods

Preserved Ejection Fraction 70

Preserved Ejection Fraction Heart Failure Peripheral Arterial Disease Cardiomyopathy 70

Dr. Smith's ECG Blog

APRIL 8, 2015

Cardiac Syncope ("True Syncope") Independent Predictors of Adverse Outcomes condensed from multiple studies 1. These premonitory symptoms were negative predictors of adverse outcomes in EGSYS. h/o heart disease (+1) 3. Aortic Dissection, Valvular (especially Aortic Stenosis), Tamponade. Syncope with Exertion (EGSYS) 7.

Arrhythmia 52

Arrhythmia Outcomes Risk Factors Chest Pain 52

Wellnest

JULY 19, 2023

It is imperative to act swiftly when faced with such a medical emergency to ensure the best possible outcome. Damage to the unattended heart in the first few hours The heart muscles begin to die within 80-90 minutes of being deprived of blood. Obesity or being overweight can increase the risk of heart disease.

Heart Attack 52

Heart Attack Heart attacks Blood Pressure Myocardial Infarction 52

Open Heart

DECEMBER 26, 2023

Objective This study describes the differences in treatment and clinical outcomes in patients aged ≥75 years compared with those aged ≤74 years presenting with acute coronary syndrome (ACS) and undergoing invasive management. Results In total, 11 763 patients were diagnosed with ACS, of which 39% were aged ≥75 years.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Outcomes Angina 40

Dr. S. Venkatesan MD

NOVEMBER 6, 2024

PH is an important clinical cardio-pulmonary entity , which we confront day to day. Though the prevalence of PH in a community is just 1 % (25 times less than systemic hypertension) it deserves a special place as the diagnosis is more complex and outcome is often adverse. The overlaps in etiology 1.The

Pulmonary 52

Pulmonary Hypertension Congenital Heart Disease Academic 52

Dr. S. Venkatesan MD

APRIL 3, 2025

In pregnant women with significant heart disease : A quick LSCS or a potentially prolonged natural delivery,which is more safe ? For women with significant heart disease (e.g., In women with significant heart disease, the physiological demands of labor (e.g., Is LSCS really more safe ?

Heart Disease 40

Heart Disease Blood Pressure Heart Failure Aortic 40

DAIC

OCTOBER 30, 2024

The PulseSelect Pulsed Field Ablation System, which was FDA approved in December 2023, offers physicians a safe, single-shot solution for pulmonary vein isolation (PVI) while the Affera Sphere-9 catheter enables physician treatment flexibility with its wide area focal design and 9mm lattice tip that can used with an 8.5Fr sheath.

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52

Frontiers in Cardiovascular Medicine

NOVEMBER 19, 2024

BackgroundWhile several studies have explored the outcomes of transcatheter interventions for modified Blalock–Taussig shunts (MBTSs) in a broad range of congenital heart diseases, none have specifically examined the interventions in patients with hypoplastic left heart syndrome (HLHS) who underwent Norwood palliation (NP).MethodsThis

Thrombosis 59

Thrombosis Stents Stent Congenital Heart Disease 59

Dr. Smith's ECG Blog

FEBRUARY 26, 2025

Rupture can be either free wall rupture (causing tamponade) or septal rupture, causing ventricular septal defect with left to right flow and resulting pulmonary edema and shock. How extensive was this patient's heart disease prior to this recent event? When did the MI begin? When was the VSR?

Chest Pain 88

Chest Pain Pericarditis Myocardial Infarction Dementia 88